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This article contains concepts that will be included
in a soon to be published book by the 
authors, Health Issues among Incarcerated Women
(Rutgers University Press). 
The prevalence of HIV infection among incar-
cerated women is disproportionately high, when
compared with non-incarcerated populations
and also when compared with the prevalence of
HIV among incarcerated men.   For example, at
the end of 2003, 2.6% of female state and fed-
eral prison inmates were reported to be HV-
infected in contrast to 1.8% of males.1 Similarly,
in a 2002 survey, 2.3% of female jail inmates
self-reported being HIV-infected as compared to
1.2% of males.2 The reasons why incarcerated
women are disproportionately impacted by
HIV/AIDS are complex, but it is notable that
many of the same life circumstances that
increase risk for HIV infection (e.g., poverty,
exposure to violence and abuse, substance
abuse, unemployment, unstable living condi-
tions) also increase the likelihood of criminal
behavior (e.g., drug use and sex work) and
therefore incarceration.  Many researchers
argue that incarceration offers an ideal opportu-
nity for the delivery of health education pro-
grams and especially HIV prevention messages
that focus on high risk behaviors.3-11 In contrast
to when they were in the community, incarcerat-
ed individuals are logistically easier to reach
with prevention and education programs; and in
theory, they are encountering fewer situations of
risk (e.g., sex while under the influence of drugs
or alcohol, anonymous sex); they are some-
times reevaluating their life choices; they have
access to medical and mental health services;
and they have fewer demands being made on
their time.  Yet to make important strides
towards reducing HIV prevalence among incar-
cerated women requires a comprehensive
approach to HIV prevention, treatment and
care.
This article will explore the complexities sur-
rounding the delivery of HIV-related services to
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Dear Corrections Colleagues, 
When I read about "gender entrapment", a concept put forth by Dr. Kim Arriola and colleagues in this issue
of IDCR, I thought about the life stories that I have heard in my 15 years of correctional HIV practice. There
were many variations on a common theme - the women were sold by their mothers to neighbors for crack,
or used as sex toys by stepfathers, or locked up in their own homes by their lovers, or beaten with two by
fours by their legal husbands, or verbally abused by their own children, or dumped out of cars and left for
dead, or gang raped and then set on fire. These women have had their dogs and their children killed in
front of their own eyes.  These women bear children that are their own siblings. And these stories are true.
I have listened to stories in my clinic that made me want to escape the telling of them - that made me won-
der how the woman sitting with me was strong enough to survive, to have children, and to get out of bed
every day. These stories were being told by women that had been entrapped by their life circumstances,
and could not see outside the room of pain that they had been locked into. 
For the fortunate few, prison was a route of escape from those lives, a path leading to a safer haven after
release.  For those few, a prison clinic could be a place where, for the first time in their lives, they could
feel as valued and as precious as they were on the day that they were made. But for many, the experi-
ence of prison was just part of a cycle of abuse that was never ending, and never changing, and hidden
from all but a few. That is what Dr. Arriola means when she says that "women often engage in illegal
behavior as a logical extension of their marginalized social positions, culturally expected gender roles, and
the violence that surrounds them".   And while she also states that the entrapment model does not absolve
individuals from personal responsibility; she suggests that it is time that we acknowledge and address the
social, cultural, financial, and political conditions that lead to illegal behavior, thus compelling women to
crime. 
We health care providers have two choices when faced with this type of exposé.  We can either continue
our same behaviors, and, like so many women in prison, never find a way to modify the certain outcome
(repeated incarcerations, continued marginalization, unending exposure to HIV risk). Alternatively, we can
seek a way to pry open that room of pain and help incarcerated women find a path to safe haven.  We
may need to reach outside of prison and jail walls, telling their true stories and calling attention to the roots
of the problem as described by Dr. Arriola. Models for change exist - and as prescribed, we can start by
bearing witness, admitting that the system has failed, find strength in our shared vision to improve cor-
rectional health care, establish common goals, and then seek a way to start anew. 
Readers of this issue of IDCR can expect to be able to identify the root causes of the higher prevalence
of HIV infection in US correctional institutions. They also can become familiar with recent reports on the
projected cost of halting the epidemic (as estimated by UNAIDS), which would require $22 billion a year
by 2008 and possibly more in the following years.
And, as always, we are pleased to have coordinated and written this issue for you, our valued colleagues
who work in correctional settings all over the US and abroad. We welcome your comments, and in order
to make it easier for you to share your thoughts with your peers, we have added a new feature on the
website - letters to the editor. Please send your letters to your editors, Annie De Groot
(AnnieD@Brown.edu) and David Wohl (Wohl@med.unc.edu). 
Annie DeGroot, MD
LETTER FROM THE EDITOR (continued from page 2)
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incarcerated women.  In doing so, it will
explore three questions:  (a) How do race,
class, and gender intersect to confer risk
for HIV/AIDS among incarcerated women?
(b) What types of HIV-related services are
needed for incarcerated women? and (c)
What aspects of correctional health care
policy are relevant to incarcerated women?
Intersection of Race, Class and Gender
Black women living in poverty are at
increased risk for HIV/AIDS and they are
disproportionately incarcerated.  For exam-
ple, in 2004, African American and Hispanic
women together in the U.S. represented
about 25% of the United States population12
yet they accounted for about 81% of the
estimated total AIDS diagnoses among
women.
13
At the same time, when examin-
ing the racial composition of female prison
population, two-thirds of women confined in
local jails, state, and federal prisons are
black, Hispanic, or of other non-white eth-
nic groups.
14
In the United States, race, class and gen-
der are linked to risk of HIV infection.
Researchers increasingly acknowledge
that the disproportionate rates of HIV/AIDS
among poor black women compared to
white women are due to the social inequal-
ities that exist within the United States.15,16
There are at least two important ways in
which the effects of race, poverty and gen-
der converge in the lives of black women:
trauma (or the experience of physical or
sexual violence) and sexuality.  First, the
combination of racism, classism and sex-
ism influences the nature and range of vio-
lence experienced by poor black women,
the male-female gender roles that may pro-
mote violence against women, the struc-
ture of social institutions that condone this
violence, and the extent to which the vic-
tims engage in help-seeking behavior.17
Second, black women's limited control over
their own sexuality has direct implications
for their ability to protect themselves from
contracting HIV/AIDS.  For example, they
may be less able to insist on condom use
or they may feel forced to use their bodies
to secure drugs or other desired goods.
Research has confirmed the relationship
between trauma and HIV risk behavior.
Child physical and sexual abuse, intimate
partner violence, and rape are interrelated
and are associated with risk for HIV/AIDS
among black women.18-24 Specifically, this
research has found these types of  trauma
are associated with engaging in sex with a
risky partner;18,21 and may contribute to
other risks including: having sex with more
than one partner,21 using drugs,18 engaging
in sex without a condom,23 and exchanging
sex for drugs, money, or shelter among
women of color.18 However, most of the
research performed to date is cross-sec-
tional, so the directional nature of the rela-
tionship between trauma and HIV risk-tak-
ing is unclear.
One explanation of the link between inti-
mate partner violence and illegal behavior
is provided by the 'gender entrapment'
model.25 This theory suggests that African-
American battered women often engage in
illegal behavior as a logical extension of
their marginalized social positions, cultural-
ly expected gender roles, and the violence
that surrounds them. This model does not
absolve individuals from personal responsi-
bility; instead it acknowledges the social,
cultural, financial and political conditions
that set them up for illegal behavior, thus
compelling them to crime.25
HIV-related services for incarcerated
women
Given the heightened risk of HIV infection
among women who are incarcerated, it is
imperative that prevention approaches be
focused on this population. A public health
approach to HIV prevention among incar-
cerated women would entail implementing
aggressive primary, secondary and tertiary
HIV prevention services. Primary preven-
tion is based on HIV prevention education
delivered to the general population of incar-
cerated women for the purpose of prevent-
ing infection. Secondary prevention focus-
es on offering infectious disease screening
(i.e. screening for sexually transmitted
infections [STIs] and HIV/AIDS) to facilitate
early detection and intervention. Tertiary
prevention is accomplished by providing
HIV treatment to those identified as being
infected to improve health and reduce the
likelihood of further spreading the infection. 
Primary Prevention
HIV and STI education and prevention pro-
grams are delivered through a variety of
modalities in correctional settings: instruc-
tor-led education, peer-led programs, multi-
session prevention counseling, pre-
test/post-test individual counseling, the use
of audiovisual materials, and the dissemi-
nation of written materials.26 HIV and STI
education programs have been widespread
in correctional facilities for both men and
women,26,27 although few have been sys-
tematically evaluated making it difficult to
ascertain their true impact.14
Bedford Hills "ACE" 
Model HIV prevention programs targeting
women have been described at several
facilities including the Bedford Hills
Correctional Facility in New York,27 where a
widely recognized peer education program
is being implemented.  The AIDS
Counseling and Education (ACE) program6
was founded in a New York prison in1988
and soon thereafter the program was rec-
ognized as a model program that could be
replicated in other facilities and began to
receive funding from the New York State
Department of Health AIDS Institute. ACE
functions as a collaborative effort among
inmates, medical and nursing staff, and the
facility administration. Participants devel-
oped a curriculum of nine education work-
shops (e.g. "What is HIV/AIDS?",
"HIV/AIDS:  Sexual transmission,"
"HIV/AIDS: Transmission and risk-reduc-
tion activities"). The curriculum entails pre-
senting issues as problems that are to be
examined and draws from the knowledge
and experience of the peer educators to
empower participants to resolve these
problems.27 The ACE program continues
and has become integrated into the recep-
tion process in New York State.
Despite the great promise that primary pre-
vention programs such as the ACE pro-
gram hold, much more work needs to be
done in this area. Firstly, there is a need for
rigorous evaluation of existing HIV primary
prevention services. Secondly, educational
and prevention programs must be tailored
to meet the unique needs of the relevant
correctional system and the needs of the
target population. Regarding the correc-
tional system, there may be policies that
dictate how, when and where HIV preven-
tion education is delivered and what the
content entails; these rules should be
respected. Regarding the target popula-
tion, educational messages should be
developed in a culturally appropriate man-
ner. Thirdly, there needs to be considera-
tion of the possibility that HIV prevention
may not be a priority for many high-risk
women because they are focusing on
meeting other needs. Therefore, substance
abuse treatment, vocational training, high
school equivalency classes, transitional
and long-term housing, legal services, and
family services may positively impact a
woman's life in a manner that results in less
HIV risk. 
Secondary Prevention, HIV Testing 
Screening for infectious diseases is a nec-
essary component of any comprehensive
HIV prevention program. HIV screening
services that are made available to incar-
cerated women in the United States vary
greatly (see IDCR April, 2006). HIV anti-
body testing may be mandatory (i.e.
required of all inmates at a particular point
in time, such as, upon entrance to or
release from a facility), routine (i.e. patients
are informed that they will be tested unless
3
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they specifically refuse), offered (i.e. staff
recommends testing to an inmate based on
a health history and assessment), on
request (i.e. no testing unless initiated by
the inmate), or a combination of these
strategies.24 The issue of HIV testing in cor-
rectional facilities is controversial as it
requires attention to both public health and
individual rights (see IDCR March, 2006). It
is further complicated by difficulties with
maintaining confidentiality in a correctional
setting, the highly stigmatized nature of
HIV/AIDS, and the potential for the use of
results to segregate those who test positive
from those who test negative.3,11,28
Tertiary Prevention
Issues surrounding the medical manage-
ment of the HIV-infected incarcerated
woman are complex and have been
reviewed in detail elsewhere.29,30 Treatment
with combination antiretroviral therapy is
the standard of care and the Department of
Health and Human Services (DHHS) has
issued clinical guidelines for the care of
HIV-infected adults - including specific
guidance on managing incarcerated
women.  DHHS guidelines highlight the
importance of early intervention, multiple
drug regimens, and adherence to treat-
ment. In addition, given that injection drug
use and unprotected consensual and non-
consensual sex are not uncommon in pris-
ons, the accessibility of post exposure pro-
phylaxis to incarcerated persons is particu-
larly important.31
Gynecological Care
Gynecological care of HIV-infected and at-
risk incarcerated women is important. The
presence of HIV infection increases
women's susceptibility to reproductive tract
infections and vice versa. Furthermore, the
presence of any STI should suggest that
the patient may also be at risk for other
STIs, including HIV. Thus, diagnosis of an
STI should prompt referral for HIV counsel-
ing and testing. In addition, the prevalence
of cervical cytological abnormalities, includ-
ing cervical dysplasia, a precursor to can-
cer, among HIV-infected women and the
recommendation for early intervention con-
firm the need for access to colposcopy.32
Mother to Child HIV Transmission
Prevention
Perinatal HIV  transmission can occur at
any time during pregnancy, labor, delivery
and breast feeding. Antiretroviral therapy is
a highly effective means of reducing the
risk of prenatal transmission and has been
recommended by the US Public Health
Service (Centers for Disease Control and
Prevention, 1995). Thus, testing pregnant
women for HIV is recommended, and anti-
retroviral therapy is a critically important
component of the health of pregnant HIV-
infected women and their children. (See
Spotlight on "Perinatal Testing and HIV
Prevention" in this issue).
In light of these recommendations and
research demonstrating the reduced likeli-
hood of perinatal transmission with the
introduction of antiretroviral therapy,33 poli-
cies to facilitate pregnancy testing for
female inmates and HIV antibody testing
for pregnant inmates have become increas-
ingly common.24 The majority of state and
federal prison systems provide pregnancy
testing upon inmate request and less than
half provide routine testing on entry.  Less
than a third of city/county jail systems rou-
tinely test all incoming female inmates.  In
terms of HIV antibody testing, it is relative-
ly common for state and federal prison sys-
tems to require mandatory HIV antibody
testing for pregnant female inmates (39%).
By contrast, the most common practice for
city/county jail systems is to offer HIV anti-
body testing to pregnant inmates (51%),
with only one jail system requiring manda-
tory HIV antibody testing for pregnant
female inmates. 
Ultimately, it would take the combination of
aggressive pregnancy policies and aggres-
sive HIV antibody testing policies to ensure
that infected pregnant inmates are started
on antiretroviral therapy as early as possi-
ble in pregnancy in order to reduce the like-
lihood of perinatal transmission.24
Discharge Planning
When the proper medical therapy is initiat-
ed during incarceration, it is important that
measures be put in place to ensure conti-
nuity of care and follow-up upon release.
After release, many HIV-infected ex-offend-
ers will lack housing, employment, trans-
portation and monetary resources.  As a
result, HIV treatment and medication
adherence may not be a high priority. One
study suggests that being released from
prison may, perversely, have a negative
impact on disease progression as indicated
by rising viral loads and falling CD4 cell
counts - risking individual and public
health.34 Furthermore, efforts at continuity
of care should be informed by evidence
that intensive discharge planning (i.e. mak-
ing an appointment for an inmate as
opposed to simply a referral) results in a
greater likelihood of follow-up.3
Considerations for Health Care Policy
Bold and progressive policy action is
required by correctional policymakers to
advance the health and well-being of incar-
cerated women.  Examples of such policy
initiatives are presented below.
1.  Develop HIV prevention and screen-
ing services with the full participation of
incarcerated women.  Following the ACE
model, services should be developed and
implemented by incarcerated women for
incarcerated women.  It is likely that these
services will be more heavily utilized if the
women feel a sense of ownership.
Moreover, peer education programs have
received support in the research
literature.35 However, for a grass-roots HIV
prevention program to develop, there must
be support among correctional administra-
tors.  
2.  Encourage HIV screening as a rou-
tine part of medical care.  In keeping with
the CDC guidelines to develop new strate-
gies to control the spread of HIV/AIDS36,
correctional health care providers should
work to create an environment in which
voluntary HIV testing is an accepted and
regular part of health care. Given that the
population being served in correctional
facilities is at such high risk for contracting
HIV, there needs to be multiple opportuni-
ties for inmates to agree to voluntary HIV
testing during incarceration.  This could
occur in the context of routine medical vis-
its, particularly when inmates present with
STIs.  What is key is that there is a per-
ception that testing is common among
inmates (i.e. just because one consents to
testing does not mean that she is posi-
tive), that results are handled with the
strictest confidentiality, and that the correc-
tional environment not impose punitive
policies towards those who are infected
(e.g. mandatory segregation).
3.  Continued improvement of HIV man-
agement and gynecologic care is an
important component of Correctional
Health Care policy. 
4.  Support an increase in discharge
planning initiatives that reinforce conti-
nuity of care for HIV infected inmates
returning to community settings. Continuity
of care for African-American and Latina
female offenders is especially daunting,
given their low representation among the
health insured.  Deliberate action is need-
ed to extend the responsibility for medical
treatment from the prison to community
settings. Interagency collaboration
between corrections and municipal health
providers will need to be legislated to
ensure extended post-release care.
5.  CBO engagement. Improved opportu-
nities for community-based organizations
and AIDS service organizations are need-
ed to gain access to incarcerated popula-
tions for delivery of HIV/AIDS education
and prevention programs.  Many state
departments of corrections and local jails
allow these organizations to offer preven-
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tion programs. Allowing community organi-
zations that provide transitional services in
correctional settings to bill for reimburse-
ment for such services will remove a sub-
stantial obstacle to community continuity
of care. 
6.  Increase training. Increased medical
and correctional staff training and educa-
tion designed to modify attitudes about
HIV among correctional personnel would
reduce stigmatization and improve access
to care, while improving the coordination
of services for HIV infected incarcerated
women.
Conclusions
A number of advances have been made in
the quality of HIV-related health care deliv-
ered to incarcerated women, due in part to
improvements in correctional health care in
general but also due to court mandates and
advocacy.  Court mandates aside, as
researchers, health care providers, correc-
tional officials and policymakers, we should
care about the health of female inmates.
Female inmates are human beings whose
rates of HIV/AIDS far exceed rates among
the general population and incarcerated
men. There are professional organizations
and accrediting bodies that help ensure the
quality of care delivered in correctional
facilities.  The National Commission on
Correctional Health Care offers health ser-
vices accreditation that correctional facili-
ties may obtain on a voluntary basis and
has issued a position statement on
women's health care in correctional set-
tings.
37
The American Psychiatric
Association, American Public Health
Association, the National Commission on
Correctional Health Care and American
Correctional Association have guidelines
for the delivery of services in correctional
settings.  All of these guidelines point to the
importance of comprehensive health ser-
vices being made available to women in
need.
It is the case that the majority of HIV-infect-
ed incarcerated women will return to soci-
ety.  Thus, it is crucial that all efforts are
made to prepare these women for reentry
into society and not have them return to the
circumstances that led them to seroconver-
sion, jail or prison.  Without reentry assis-
tance, women are likely to return to the
criminal and health risk behavior that lead
to their incarceration.  Health concerns not
addressed during incarceration will still
exist once the ex-offender has returned to
the community.  Upon release, any infec-
tious disease that an ex-offender has, for
example, may be transmitted to individuals
in the general population.  It is for this rea-
son that many public health professionals
argue that HIV prevention programs imple-
mented by correctional policymakers to
advance the health and well-being of incar-
cerated populations will ultimately impact
the community at-large.
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Introduction
Despite tremendous success in reducing
perinatal HIV transmission in the United
States, medical and pharmacological inter-
ventions have proven insufficient to eradi-
cate this route of HIV infection.1 Most HIV-
infected women engage in comprehensive
medical care with utmost concern for the
health of their anticipated newborn.2 Those
who do not are at very high risk for vertical
transmission.3
In 2000, the Pediatric AIDS Chicago
Prevention Initiative (PACPI) assembled
HIV advocates, social service providers,
and medical personnel to identify strategies
to eradicate perinatal HIV transmission in
Chicago.  They identified common experi-
ences and characteristics of Chicago
women who gave birth to HIV-exposed and
infected babies.  The most prevalent kind of
institutional contact among this group of
HIV-infected women was with the child wel-
fare system, either as a ward or as a parent
of an involved child.  PACPI then provided
funding to investigate the forces affecting
care for HIV-infected women involved with
the Illinois Department of Children and
Family Services (IDCFS). 
An interdisciplinary research team
designed a qualitative study to explore the
barriers to care perceived by childbearing,
HIV-infected women with current or prior
IDCFS involvement.  Using a feminist theo-
retical perspective, our inquiry regarded
these women as expert informants on their
own condition and accepted their views as
valid explanations for the conditions that
inhibit access to and engagement in care
that could prevent HIV transmission to their
children.  The details of this study were
published in the Journal of Social Science
and Medicine.4 Here, we briefly summarize
aspects relevant to providers working with
incarcerated women with HIV. 
Methods
With the IDCFS and the University Chicago
institutional review boards' approval, we
used the IDCFS HIV mothers database to
identify 32 women who knew their HIV sta-
tus and had given birth to at least two chil-
dren since 1997 (the year zidovudine use to
prevent vertical transmission became wide-
spread).  Fourteen of these women were
located by IDCFS personnel (under the
supervision of our IDCFS collaborator), and
12 agreed to participate.  Three additional
women meeting these criteria and pregnant
at the time of recruitment were also
enrolled.  Respondents' identities remained
anonymous to the co-investigators.  A pro-
fessional interviewer conducted the inter-
views to further protect participants'
anonymity.  Semi-structured, in-depth inter-
views probed three major domains: 1) moti-
vations for childbearing; 2) experiences
with the health and child welfare systems;
3) perspectives on strategies to eradicate
vertical transmission.
Results
The women described life conditions at the
extreme margin of poverty and deprivation.
Most were chronically unemployed, living
below the U.S. poverty line. Many had
experienced homelessness and physical,
sexual and/or emotional abuse as children
and/or as adults.  Substance use and
dependence were prevalent.   Exhibiting an
average birth rate of more than twice the
U.S. average, 62 men had fathered 78 chil-
dren (9 HIV infected) to these 15 women.
Although we did not explicitly inquire about
contact with the criminal justice system,
several women referred to such contact,
particularly among their sexual partners
and children's fathers.   Nearly every
woman indicated that she had no friends.
Figure 1 provides a composite simplified
life event history of these women.
Many women asserted their desire to give
birth to and parent a healthy child, but most
did not use contraception and described
their pregnancies as unplanned.  Only 3
received appropriate prenatal care.
Motivations for childbearing included a
desire to replace children removed from
custody, to demonstrate capacity to parent,
and to fill an emotional void.  Two women
talked about childbearing as a way to "fight"
HIV or avoid the appearance of being HIV-
infected.  One woman commented: "If I did-
n't have the baby, people would wonder
why and what was wrong. I was trying to
prove to people that I wasn't what I really
was."  
Every woman knew her HIV status prior to
the birth of at least two of her children,
knew of the availability and importance of
antiretroviral therapy and prenatal care and
most believed that such therapy could sub-
stantially reduce the likelihood of infecting
the newborn.  However, descriptions of
contact with the health and child welfare
systems were largely negative.  Women
routinely experienced interactions as disre-
spectful, judgmental and dehumanizing.
They avoided care because of negative
practices by medical personnel, including
disrespectful and condescending treat-
ment, lack of privacy, and egregious
breaches of confidentiality.  These experi-
ences included expressions of disdain or
disgust from medical personnel, discrimina-
tion with regard to medical treatment due to
HIV status, inadequate explanations
regarding disease process and treatment,
and diminution of rights to privacy and con-
fidentiality.  One woman stated, "A person
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Figure 1. Life Histories of HIV+ Mothers
Fig. 1. Reprinted from Social Science and
Medicine, Vol. 62 Issue 1, Lindau S T, et al.,
Mothers on the margins: Implications for eradi-
cating perinatal HIV, pp. 59-69, 2006, with per-
mission from Elsevier.
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who is positive should have control over
who they decide to tell and who not…Other
people seemed to just know. Medical staff
would just talk about it right in front of me at
the hospital and with other staff around."
Women also felt betrayed and/or confused
by what was perceived as collusion
between the child welfare and the medical
system around sharing of client/patient
information. As a consequence, many
women related that a major hindrance to
engagement in prenatal care was an inabil-
ity to confidentially disclose their HIV status
to providers. 
Substance use and denial about HIV status
were cited as important barriers to prenatal
care. More than half described such periods
of denial or being "in a daze;" two-thirds
claimed current or past substance use.
Several women described substance use
as a way to escape the reality of HIV infec-
tion.  "When you first find out you are posi-
tive, you go through a state of denial and
depression. You get mad. You tell the doc-
tor you are not HIV+...At first I was in a state
of denial. I went out there and used. I felt
like I just wanted to do my thing." 
Participants were asked how to improve
HIV-infected women's participation in pre-
natal care.   Women desired respectful and
humane treatment and messages promot-
ing prenatal care which emphasized the
health of the newborn or the consequences
to the newborn should care be neglected.
Several women commented that they want-
ed explicit and detailed information about
therapies and about the impact of these on
markers of disease status (e.g. T-cell
counts).  Although social support was
absent or scant for most participants, six
women depended on positive relationships
with health or social service professionals
for accessing and accepting medical care.
Several women also suggested the value of
peer counselors to motivate care. 
Discussion
Stigma combined with economic and social
poverty threaten the possibility that highly
efficacious medical interventions can
accomplish eradication of vertical transmis-
sion of HIV in the U.S.5 Efforts to accom-
plish eradication must address the environ-
ment of care for marginalized women.
SPOTLIGHT...
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These are portraits drawn from life with the enthusiastic consent of the Texas women prisoners involved. They have agreed to share their per-
sonal stories to increase awareness about risks that contribute to HIV infection. Dr. Eric Avery and Sue Coe, spent a week at UTMB interviewing
and drawing six women who are HIV Positive, at the invitation of Dr. David Paar. The women are peer group educators, supportive of other women
within the prison system who have found out they are also positive, but their support is probably most effective in talking with those negatives who
remain at risk.
The drawings, 15 inches x 10 inches, done in conte crayon, are a type of visual journalism:  they reconstruct events from the women's life sto-
ries.  A selection of these works can be seen at http://graphicwitness.org/coe/utmb.htm. Sue, Eric and David, had worked together previously at
UTMB at the beginning of the AIDS pandemic, showing through art the patients in the Infectious Disease Ward.  In those days all the patients Sue
drew died.  When the work is completed it will be published as a book entitled "Through Her Own Eyes".
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Clinical
? The majority of HPV infections are both asymptomatic and subclinical.
? Genital warts are most frequent with strains 6 and 11.
? Cervical, anal intraepithelial lesions, and vaginal vulvar dypla- 
sia and malignancies are most often associated with oncogenic 
strains 16, 18, 31, 33, and 35.
? HIV: Clinical manifestations occur at any CD4; more advanced dis-
ease associated with persistence of oncogenic strains. Lower CD4 T
cell count associated with persistence and increased risk of premalig-
nant and malignant lesions. Increasing risk of squamous intraepithe-
lial lesions, and manifestations where standard therapy may not be as
effective.
? Anogenital warts are usually detected by visual inspection; Bx is
required to rule out malignancy or to confirm HPV-related epithelial
changes if Dx unclear visually. 
? Intraepithelial  lesions (cervical, anal, etc) indicated by "Pap smear"
followed by colposcopy or high resolution anoscopy with biopsy.
? Cervical Pap smear in HIV+ women has utility similar to that in HIV-
women for identification of high-grade cervical lesions.
? In HIV+ women, cervical Pap recommended at baseline evaluation
and 6 mos; then annually after 2 sequential normal tests. Any abnor-
mal result (atypical cells of undetermined significance [ASCUS], low
grade squamous Intraepithelial  lesion [L-SIL], high grade squamous
Intraepithelial  lesion [H-SIL], atypical cells, cannot exclude H-SIL
[ASC-H], and atypical glandular cells [AGC]) should lead to col-
poscopy with biopsy.
? High rates of anal dysplasia in men who have sex with men and can
also occur in women; cytologic screening ("anal Pap") may be useful
for cancer prevention. However, the most effective screening intervals
and management of abnormal cytology has not been established. In a 
Prevention
? Condom use (incomplete protection due to possible transmission of
HPV from contact with perineum, scrotum and peri-genital area). 
? Regular Pap tests for women and men who have sex with men.
? HPV vaccine prior to "sexarche" (onset of sexual activity) to help pre-
vent genital HPV infection as well as HPV-associated diseases such
as genital warts and cervical cancer. However, existing HPV vaccines
will not prevent all types of HPV infection and therefore should not
replace other prevention strategies.
HPV Vaccine
? Merck's recombinant vaccine, Gardasil, was FDA approved on
06/08/06. 
? This vaccine prevents cervical cancer, precancerous genital lesions,
and genital warts caused by HPV types 6, 11, 16 and 18.
? Gardasil is approved for use in women ages 9-26.  It is administered
as three injections within a 6-month period. 
? Immunization before the onset of sexual activity offers the most pro-
tection since women are most likely to be naïve to all 4 HPV types
(6,11,16,18) covered by the vaccine prior to sexual debut, although
studies of sexually active women, ages 9-26, who received Gardasil,
show that they still achieved protection from vaccination (because
these women were still naïve to one or more of the HPV types includ-
ed in the vaccine after sexual debut).
? Gardasil does not protect against other less common types of HPV, so
women will continue to need regular PAP tests or HPV screening.
Treatment - Genital Warts
? Podophyllotoxin/podofilox (0.5% gel, solution or cream) topical appli-
cation once every week x 6 weeks
? Imiquimod topical administration 3 times a week to the wart (leave on
for 6-10 hrs, then wash off). Continue until complete resolution.
? Cryotherapy: liquid nitrogen (applied by clinician)
? Bichloroacetic acid or trichloroacetic acid (applied by clinician)
? Wart clearance and recurrence rates similar for treatments cited,
though patient-applied therapies less costly overall.
Treatment - Premalignant and malignant lesions - managed by Gyn
Oncologist
? Local excision (i.e. LEEP), confirm that margins are clear. 
? Cryotherapy also acceptable for mild neoplasia (i.e. CIN 1) with no
disease in the endocervical canal.
? Wide excision and chemotherapy if invasive.
Risk Behavior
? Sexual behavior is the principal risk factor for infection. Women with
multiple sexual partners have a higher risk of contracting HPV than
monogamous women. Almost all adults are HPV infected by late mid-
dle age. 
? Immune suppression is a risk factor for all people exposed to HPV. A
person with a pre-existing immuno-compromised state and/or concur-
rent genital infection has a 17-fold increased risk of developing HPV-
associated diseases.
Modified from:  Emily Erbelding. Johns Hopkins Medical School HIV Guide:
Human papillomavirus (HPV). 2004
Microbiology
? Non-enveloped DNA virus
? More than 35 HPV subtypes that cause anogenital infection
? Immunity not cross-reactive (from one subtype to the next)
? Exposure to virus almost universal among sexually active adults
Sites of Infection
? Vagina/Perineum
? Cervix (Particularly at the squamo-columnar junction)
? Anus (Particularly among men who have sex with men (MSM) and
Women)
? Penis/Scrotum
Most Common Modes of Transmission
? Sexual contact
Clinical Continued... 
number of centers screening at 6-12 month intervals is the practiced
standard. Abnormal Pap results are managed with high resolution
anoscopy and biopsy of suspicious lesions and are performed with
any abnormal PAP result.
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Merck's HPV Vaccine Approved by the FDA
On June 8, 2006 the Food and Drug Administration
approved the first Human Papillopavirus (HPV) vaccine.
Merck's Gardasil is the first recombinant vaccine to prevent
cervical, vulvar, and vaginal cancer, precancerous genital
lesions, and genital warts associated with HPV types 6, 11,
16 and 18. In four studies of 21,000 women, Gardasil was
nearly 100% effective against precancerous cervical
lesions, precancerous vaginal and vulvar lesions, and geni-
tal warts caused by the HPV types the vaccine was created
to prevent. The vaccine was approved for use in women
ranging in age from 9-26 years and consists of three immu-
nizations within a 6-month window. 
Although the vaccine is effective against 70% of the HPV
types (16 and 18) that cause cervical cancer and 90% of the
HPV types (6 and 11) that cause genital warts, the vaccine
does not prevent HPV in those previously exposed to the
virus before they were immunized. Given this limitation,
providers suggest that the vaccine be given to females
before the onset of sexual activity. What's more, since the
vaccine does not prevent against other less common types
of HPV, regular PAP tests remain vitally important. 
The U.S. Food and Drug Administration. FDA News. Available
at:
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html.
June 8, 2006. 
Release from Jail: Moment of Crisis or Window of
Opportunity for Female Detainees
A study by McLean and colleagues in Baltimore suggests
that pre-release planning and a continuum of care are cru-
cial to the success of female detainees once released from
jail. To identity the factors associated with perceived avail-
ability of material and social resources upon release, the
authors of the study conducted a cross-sectional study of
148 female inmates in the Baltimore City Detention Center
in 2005. Interviews of the detainees centered on drug use
and sexual histories, socio-demographic backgrounds, and
the perceived availability of material and social resources
the women will have upon release. 
The majority of the subjects (69%) were African-American
and 67% reported having an income less than $400 a
month. Less than half had their high school degree or GED
certificate. A monthly income of more than $400 and signifi-
cant familial support positively affected participant's percep-
tions of housing stability upon release. Moreover, an esti-
mated one third of the subjects were former sex workers.
Wanting a support group for issues surrounding former
engagement in sex work was negatively associated with
perceptions regarding housing ability. This finding suggests
that female sex workers may be alienated from vital social
and economic services that are essential to successful reen-
try. Other factors that negatively affected perceptions of
post-release housing stability included recent daily use of
heroin, cocaine or benzodiazepines and lack of health insur-
ance and inability to afford drug treatment. 
The authors suggest that the study results highlight areas
where interventions can be applied to help ensure success-
ful community re-entry such as vocational training and other
methods to help releasees generate legal income post-
release, as well as family-based interventions to help devel-
op and strengthen family support.  Special attention is need-
ed to address the needs of those women who have been
engaged in sex work.    Given the brief time most women
spend in jail, correctional system and the public health sec-
tor should collaborate to provide female detainees a contin-
uum of care between jail and communities. 
McLean RL, Robarge J, and Sherman SG. Release from Jail:
Moment of Crisis or Window of Opportunity fir Female
Detainees. Journal of Urban Health: Bulletin of the New York
Academy of Medicine. 2006:83(3):382-383.
Poverty Fuels HIV among African American
Heterosexuals With and Without High Risk
Behaviors 
Rates of HIV transmission via heterosexual sex is much
higher among African-Americans than whites - particularly
among African-American women (see next report) - and the
racial disparity in heterosexual acquisition of HIV infection is
most pronounced in the South.  To determine risk factors for
HIV infection among heterosexual African-American men
and women in North Carolina, Adimora and colleagues con-
ducted a cross-sectional study of 206 African-American HIV-
positive men and women (cases) recruited during HIV post-
test counseling sessions and 226 HIV-negative adults (con-
trols) selected from a random sample identified through
state motor vehicle records.  Controls were tested for HIV
infection at enrollment.  All participants reported being het-
erosexual and denied injection drug use.
In-depth one-on-one interviews were conducted and
revealed that cases were more likely to be unmarried, have
less than a high school education, earn less than $16,000
per year, be uninsured, have been homeless, have spent at
least 24 hours incarcerated, and be concerned about having
enough food.  In addition, although both groups had high
levels of unprotected sex with recent partners, cases report-
ed having other high risk behaviors such as more sex part-
ners, concurrent partnerships, anal sex, sex for
drugs/money, use of crack cocaine, and heavy alcohol use.  
While greater risk behavior among cases was not unexpect-
ed, about a quarter of the cases denied significant risk fac-
tors.  Compared to low-risk controls, cases were more likely
to be young and unmarried, report lower education level,
have been incarcerated and, importantly, be poor as mea-
sured by annual income and food insecurity.  
The finding that a substantial proportion of heterosexual
African-Americans with HIV-infection report low risk behav-
iors suggests that HIV infection has become endemic in the
rural South.  Further, the association of HIV infection in the
group as a whole and among the significant proportion low
risk individuals with low socioeconomic status supports a
major role of economic inequality as a facilitator of trans-
mission.  While education about personal risk factors and
greater condom use is key to preventing the spread of HIV,
the researchers conclude, public policy also needs to
address the social and economic disparities that put African-
Americans at greater risk of infection.
Adimora AA, Schoenbach VJ, Martinson FEA, et al.
Heterosexually Transmitted HIV Infection Among African
Americans in North Carolina. JAIDS Journal of Acquired
Immunodeficiency Syndromes. 2006:41(5):616-624. 
HIV-Infection among Women: African-American
Women in the South at Greatest Risk
The majority of the HIV infection cases reported among
women in the United States between 1999 and 2003 are in
the South and among racial/ethnic minorities, according to
officials from the Centers for Disease Control and
Prevention (CDC) and reported in USA Today.  Data from
the 32 states reporting HIV infection (rather than only AIDS)
to the CDC indicate that 76% of new cases of HIV infection
among women occurred in women in the South - even
though only 29% of women in the country live in that region.
Further, it is minority women who are disproportionately
becoming infected.  Lisa Fitzpatrick, an author of the report,
quoted in the USA Today article, highlighted that, "HIV diag-
noses were four times higher among Hispanic women and
18 times higher in black women than white women" and
that,  "seventy-one percent were infected through hetero-
sexual sex."  In addition, girls ages 13 to 19 in the South are
increasingly affected by HIV; 8% of new HIV diagnoses in
the South occur in that age group, four times the rate found
in other parts of the country. 
NEWS AND LITERATURE REVIEWS
Continued on page 10
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RESOURCES
Bureau of Justice Prison Statistics
http://www.ojp.usdoj.gov/bjs/prisons.htm
CDC. Genital HPV Infection Fact Sheet
http://www.cdc.gov/std/HPV/STDFact-HPV.htm
CDC. HPV Vaccine Question and Answer
http://www.cdc.gov/std/HPV/STDFact-HPV-vaccine.htm
CDC. HIV/AIDS Surveillance in Women
May 2006
http://www.cdc.gov/hiv/topics/surveillance/resources/slides/
women/index.htm
AIDS Education and Training National Resource Center. Maternal-
Child HIV Transmission Guide
http://www.aids-ed.org/aidsetc?page=et-30-19&catid=mtct&pid=1
Maternal-Child HIV Transmission Perinatal Guidelines
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=
Guidelines&Search=Off&GuidelineID=9&ClassID=2
Women, Children, and HIV: Resources for Prevention and Treatment
http://womenchildrenhiv.org/
MTCT Plus Initiative (Mailman School of Public Health at Columbia
University Maternal-Child HIV Transmission Initiative)
http://www.mtctplus.org
International Community of Women with HIV/AIDS
http://www.icw.org/tiki-view_articles.php
AIDS Alliance for Children, Youth & Families 
http://www.aids-alliance.org/aids_alliance/index.html
The Well Project: Health Information for Women with HIV and AIDS
http://www.thewellproject.org/ 
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Fitzpatrick proposed several next steps in reducing
acquisition of HIV by young black  women.  First, is
the engagement of male partners with initiatives
aimed at enhancing testing and prevention.  Further
study of the prevention needs of men should be
undertaken as should investigations of the role
incarceration and the 'down low' phenomenon on
HIV rates among women.  Second, primary preven-
tion (see main article) for young women and girls
must be supported and strengthened.  Lastly, HIV
and sexually transmitted infection education and
testing must be better integrated to reduce missed
opportunities to detect HIV infection. 
The Kaiser Daily Health Policy Report. Available at
http://www.usatoday.com/news/health/2005-06-14-hiv-
south_x.htm
or
http://www.kaisernetwork.org/daily_reports/rep_index.cf
m?hint=1&DR_ID=30762. June 15, 2006.
The Survival Benefits of AIDS Treatment in
the United States  
Combination HIV therapy is potent, increasingly
well-tolerated and has led to a dramatic decline in
progression to AIDS and death.  However, HIV care
and treatment is expensive costing the Unites
States government alone billions of dollars per year.
On the 10th anniversary of the approval of the first
protease inhibitor, Walensky and colleagues ana-
lyzed the cumulative survival benefits of AIDS care
in the United States since 1989 to 2003 - a period
that spans the eras of offering only PCP prophylax-
is to patients with AIDS to highly active antiretroviral
therapy.
Incremental advances in HIV care including prophy-
laxis of opportunistic infections, the adoption of
interventions to prevent mother to child HIV trans-
mission, the advent of combination antiretroviral
therapy and the sequencing of HIV therapy to pro-
vide opportunities for salvage have each led to
increases in per person survival. The authors esti-
mate that treatment has saved almost 3 million
years of life and 2,900 averted cases of pediatric
HIV infection. 
The quantification of the benefits of antiretroviral
therapy at the population level compliments the data
on decreasing death rates and lower AIDS case
report in the United States. A typical person living
with HIV infection receiving potent combination anti-
retrovirals can expect to live at least 13-14 years
longer than if she or he were to pass up this thera-
py or if it were unavailable.  In comparison, similar
analyses have found that chemotherapy for non-
small cell lung cancer yields an average survival
benefit of 7 months and bone marrow transplanta-
tion for relapsing non-Hodgkins lymphoma 92
months.
A major finding of this analysis is that the economic
and humanitarian benefits of HIV care are even
greater than were previously appreciated.  Given
the vast amount of life-years saved by HIV care, the
authors suggest that testing must become a routine
element in medical screening so that the benefits of
care can be enjoyed by those unaware of their HIV
infection.  Further, the results demonstrate the
potential to save hundreds of millions of lives if HIV
care were accessible to the millions living in nations
where such care is lacking.
Walensky RP, Paltiel AD, Losina E, et al. The Survival
Benefits of AIDS Treatment in the United States. The
Journal of Infectious Diseases. 2006;194(1):11-19. 
Updated Guidelines on Initial Treatment of
HIV Released by the US DHHS
The Department of Health and Human Services
updated the Guidelines for the Use of Antiretroviral
Agents in HIV-1-Infected Adults and Adolescents on
May 4, 2006.  The revised guidelines strengthen the
recommendation that genoptypic resistance testing
be performed among those yet to receive HIV ther-
apy including patients with acute HIV infection,
patients with chronic HIV infection prior to initiation
of HIV therapy and pregnant women with HIV infec-
tion prior to therapy initiation.  These recommenda-
tions follow data that suggest substantial rates of
transmitted drug resistant HIV and the effectiveness
of treatment based on baseline genotype results.
Revised recommendations regarding treatment
interruption were also included in the update and
include considerations for short and long term treat-
ment discontinuation as well as in patients with
active HBV infection receiving antiretrovirals with
anti-HBV activity.
Available at www.aidsinfo.nih.gov. May 4, 2006.
UNAIDS 2006 Report on the Global AIDS
Epidemic 
A report by UNAIDS released on May 30th, 2006
while citing positive trends in HIV prevention and
treatment, calls for significant acceleration of the
AIDS response. The report contends that halting the
epidemic will require $22 billion a year by 2008 and
possibly more in the following years. This figure is
almost triple the $8.3 billion spent last year by all
sources, including governments and the private sec-
tor and half would be aimed at prevention efforts
and a quarter for treatment and care of infected peo-
ple. The remainder of the funds would be for care of
orphans, children at risk of becoming infected and
program costs.
United Nations Secretary General Kofi Annan,
speaking to the General Assembly at the onset of a
three-day meeting aimed at renewing the political
commitment to combating the HIV epidemic, pushed
for nations to recognize that a costlier and more sus-
tained effort was needed because AIDS "has spread
further, faster and with more catastrophic long-term
effects than any other disease."  
In 2003, the World Health Organization (WHO)
launched its 3 by 5 initiative to bring HIV therapy to
3 million people living with HIV infection in low and
middle income nations by the end of 2005.
However, by this deadline little more than a million
people in developing countries received HIV treat-
ments.  
Peter Piot, Executive Director of UNAIDS urged
nations to demonstrate "sustained attention and the
kind of 'anything it takes' resolve that member states
apply to preventing global financial meltdowns or
wars," in fighting HIV.
Lawrence KA. UN Urges Tripling of Funds by '08 to Halt
AIDS. The New York Times. Available at 
http://www.nytimes.com/2006/06/01/world/01aids.html?
_r=1&n=Top%2fReference%2fTimes%20Topics%2fPe
ople%2fA%2fAltman%2c%20Lawrence%20K%2e&oref
=slogin. June 1, 2006.
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1.  According to Arriola and colleagues, ways in which the effects  
of race, poverty and gender converge in the lives of Black 
women include:
A. Trauma, such as physical or sexual violence
B. Limited control over sexuality including limited ability to 
negotiate condom use and pressure to engage in sex 
work 
C. A and B
D. None of the above
2.  Which of the following statements regarding HIV prevention 
services are TRUE:
A. Primary prevention includes education to prevent unin-
fected people from acquiring HIV
B. Secondary prevention includes screening for infection to 
enable early detection and intervention
C. Tertiary prevention involves the treatment of HIV to 
improve health and reduce the likelihood of transmission
D. All of the above
3.  The AIDS Counseling and Education (ACE) program in New 
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A. was created by correctional officers to provide informa-
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Island
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4.  In a recent report, UNAIDS stated: 
A. Current funding levels are sufficient to meet the costs of 
providing HIV care to those in developing nations
B. A tripling of current funding from public and private 
sources was now required to adequately combat the 
global HIV epidemic
C. The world has met the World Health Organization goal 
of providing HIV therapy to 3 million people in develop-
ing countries by the end of 2005 (i.e. the 3 x 5 initiative)
D. None of the above
5.  Condoms offer complete protection against infection of HPV 
(TRUE or FALSE)?
A. True
B. False
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